Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000887471) titled 'Study to evaluate the Safety and Early Effects of Tinodasertib in People who are overweight or Have Obesity' on Aug. 15.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety
Primary Sponsor: Karyogen
Condition:
Obesity
Obesity
Metabolic and Endocrine - Metabolic disorders
Diet and Nutrition - Obesity
Intervention:
This study is a Phase 1b, single center, randomised, placebo-controlled, double-blind, parallel design study to assess the safety and tolerability of 3 doses of tinodase...